celastrol has been researched along with Adenocarcinoma, Basal Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Hao, RM; Li, YJ; Ma, X; Ma, Y; Sun, YX; Wang, PY; Wu, P; Xie, N; Xie, SY; Zhang, LJ | 1 |
| Guerram, M; Hamdi, AM; Hassan, HM; Jiang, ZZ; Yousef, BA; Zhang, LY | 1 |
2 other study(ies) available for celastrol and Adenocarcinoma, Basal Cell
| Article | Year |
|---|---|
miR-33a-5p enhances the sensitivity of lung adenocarcinoma cells to celastrol by regulating mTOR signaling.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Animals; Apoptosis; Cell Line, Tumor; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; MicroRNAs; Middle Aged; Pentacyclic Triterpenes; Signal Transduction; TOR Serine-Threonine Kinases; Triterpenes; Xenograft Model Antitumor Assays | 2018 |
Pristimerin demonstrates anticancer potential in colorectal cancer cells by inducing G1 phase arrest and apoptosis and suppressing various pro-survival signaling proteins.
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Cell Cycle Proteins; Cell Line, Tumor; Colorectal Neoplasms; Drug Screening Assays, Antitumor; G1 Phase; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; Membrane Potential, Mitochondrial; Neoplasm Proteins; Pentacyclic Triterpenes; Signal Transduction; Triterpenes | 2016 |